Bio-Path Holdings, Inc(NASDAQ:BPTH) 
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA...
Website: http://www.biopathholdings.com
Founded: 2000
Full Time Employees: 9
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.16
H 0.18
L 0.15
C 0.18
V 31,830
10EMA 0.18
20EMA 0.18
60EMA 0.18
120EMA 0.18
250EMA 0.18